Literature DB >> 27542374

Gastric Outlet Obstruction due to Gastrointestinal Amyloidosis.

Jared A Cohen1, Jong An2, Alexander W Brown2, Darren Spearman3, Angelo Paredes3.   

Abstract

A 64- year-old man with smoldering myeloma presented to the hospital for nausea, vomiting, and PO intolerance. Abdominal CT demonstrated massive gastric distention and collapsed proximal duodenum consistent with gastric outlet obstruction (GOO). Esophagogastroduodenoscopy demonstrated pyloric edema. Duodenal biopsies were consistent with AL amyloidosis. Given the concerns for bleeding risk and immediate need to start chemotherapy, surgery was deferred. Chemotherapy was initiated with a good clinical response. Our non-operative approach is novel, eliminates perioperative adverse events, allows for early initiation of chemotherapy, and can serve as a model for patients with GOO resulting from AL amyloidosis who are not surgical candidates.

Entities:  

Keywords:  Amyloidosis; Chemotherapy; Gastric outlet obstruction; Multiple myeloma; Non-operative management

Mesh:

Year:  2016        PMID: 27542374     DOI: 10.1007/s11605-016-3248-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  3 in total

1.  Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study.

Authors:  Sara Bringhen; Maria Teresa Petrucci; Alessandra Larocca; Concetta Conticello; Davide Rossi; Valeria Magarotto; Pellegrino Musto; Luana Boccadifuoco; Massimo Offidani; Paola Omedé; Fabiana Gentilini; Giovannino Ciccone; Giulia Benevolo; Mariella Genuardi; Vittorio Montefusco; Stefania Oliva; Tommaso Caravita; Paola Tacchetti; Mario Boccadoro; Pieter Sonneveld; Antonio Palumbo
Journal:  Blood       Date:  2014-05-22       Impact factor: 22.113

2.  Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein.

Authors:  S Tada; M Iida; T Yao; T Kitamoto; T Yao; M Fujishima
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

3.  Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis.

Authors:  D M Menke; R A Kyle; C R Fleming; J T Wolfe; P J Kurtin; W A Oldenburg
Journal:  Mayo Clin Proc       Date:  1993-08       Impact factor: 7.616

  3 in total
  1 in total

1.  Gastric amyloidosis in a patient with dysphagia.

Authors:  Sami Ghazaleh; Anay Hindupur; Christian Nehme; Yasmin Khader; Marcel Ghanim; Taha Sheikh; Tarik Alhmoud
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.